XML 17 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
Basis of Presentation - Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Effect on income before income taxes $ (296) $ (230) $ (864) $ (603)
Effect on income taxes 40 36 134 196
Effect on net income $ (256) $ (194) $ (730) $ (407)
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Beginning Outstanding (in shares)     35,203 69,154
Released (in shares)     (21,663) (30,828)
Ending Outstanding (in shares) 13,540 38,326 13,540 38,326
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Beginning Outstanding, Weighted Average Grant Date Fair Value (usd per share)     $ 10.13 $ 10.13
Released, Weighted Average Grant Date Fair Value (usd per share)     11.47 10.08
Ending Outstanding, Weighted Average Grant Date Fair Value (usd per share) $ 7.98 $ 10.17 $ 7.98 $ 10.17
Restricted Stock | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Option vesting period (in years)     4 years  
Restricted Stock | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Option vesting period (in years)     2 years  
Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding at beginning of period (in shares)     1,063,324 1,059,417
Granted (in shares)     327,500 272,906
Assumed - merger (in shares)     367,229  
Exercised (in shares)     (94,454) (263,358)
Forfeited (in shares)     (26,571) (4,546)
Outstanding at end of period (in shares) 1,637,028 1,064,419 1,637,028 1,064,419
Exercisable at end of period (in shares) 1,005,690 663,220 1,005,690 663,220
Weighted average fair value of options granted during the period (usd per share)     $ 5.91 $ 4.38
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]        
Outstanding at beginning of period, Weighted Average Exercise Price (usd per share)     7.37 6.71
Granted, Weighted Average Exercise Price (usd per share)     9.74 $ 7.01
Assumed - Merger, Weighted Average Exercise Price (usd per share)     14.19  
Exercised, Weighted Average Exercise Price (usd per share)     5.51 $ 4.31
Forfeited, Weighted Average Exercise Price (usd per share)     29.48 8.71
Outstanding at end of period, Weighted Average Exercise Price (usd per share) $ 9.12 $ 7.37 9.12 7.37
Exercisable at end of period, Weighted Average Exercise Price (usd per share) $ 9.75 $ 8.14 $ 9.75 $ 8.14
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]        
Risk free interest rate     2.00% 2.00%
Expected life     6 years 6 years
Dividend rate     0.00% 0.00%
Volatility     67.00% 69.00%
Stock Options | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Option expiration period (in years)     10 years  
Option vesting period (in years)     4 years  
Stock Options | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Option vesting period (in years)     2 years